Sandra J. Armento

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose <i>in vivo</i>

William H. Martin, Dennis J. Hoover, Sandra J. Armento et al. · Proceedings of the National Academy of Sciences · 1998 · 230 citations · Full text

Glycobiology, Metabolic Remodeling, Experimental Pharmacology +17

Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase

Dennis J. Hoover, Sheri Lefkowitz-Snow, Jana L. Burgess-Henry et al. · Journal of Medicinal Chemistry · 1998 · 102 citations · Full text

Cardiovascular Pharmacology, Altmetric Attention Score, Pharmacotherapy +17

A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models:  6-(5-Chloro-3-methylbenzofuran- 2-sulfonyl)-2-<i>H</i>-pyridazin-3-one

Banavara L. Mylari, Sandra J. Armento, David A. Beebe et al. · Journal of Medicinal Chemistry · 2003 · 68 citations · Full text

Oral Bioavailability, Aldo-keto Reductase, Glycobiology +17

A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models:  6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2<i>H</i>-pyridazin-3-one and Congeners

Banavara L. Mylari, Sandra J. Armento, David A. Beebe et al. · Journal of Medicinal Chemistry · 2005 · 65 citations · Full text

Medicinal Chemistry, Aldo-keto Reductase, Biochemistry +15